68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol

被引:79
|
作者
Ruf, Juri [1 ,2 ]
Schiefer, Jan [1 ]
Furth, Christian [1 ]
Kosiek, Ortud [1 ]
Kropf, Siegfried [3 ]
Heuck, Friederike [4 ]
Denecke, Timm [2 ]
Pavel, Marianne [4 ]
Pascher, Andreas [5 ]
Wiedenmann, Bertram [4 ]
Amthauer, Holger [1 ,2 ]
机构
[1] Univ Klinikum Magdeburg AoR, Klin Radiol & Nukl Med, D-39120 Magdeburg, Germany
[2] Charite, Campus Virchow Klinikum, Klin Strahlenheilkunde, D-13353 Berlin, Germany
[3] Otto Von Guericke Univ, Fak Med, Inst Biometrie & Med Informat, Magdeburg, Germany
[4] Charite, Campus Virchow Klinikum, Med Klin MS Hepatol & Gastroenterol, D-13353 Berlin, Germany
[5] Charite, Campus Virchow Klinikum, Klin Allgemein Viszeral & Transplantat Chirurg, D-13353 Berlin, Germany
关键词
neuroendocrine tumor; NET; Ga-68-DOTATOC; PET/CT; multiphase CT protocol; CARCINOID-TUMORS; CONTRAST-MEDIUM; HELICAL CT; MANAGEMENT; INTERFERON; METASTASES; IMPACT; GA-68; LIVER;
D O I
10.2967/jnumed.110.083741
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The diagnostic value of neuroendocrine tumor (NET) imaging using PET with integrated CT is dependent on both components. This retrospective study assessed the value of the single CT phases of a triple-phase (early arterial, portal-venous inflow, and venous) CT protocol in comparison to Ga-68-DOTATOC PET in a masked reading. Methods: Ga-68-DOTATOC PET/CT examinations from 51 patients with known or suspected NET were included. Two readers assessed the data of PET and each of the 3 CT phases for NET lesions independently (using a 3-point score: 1 = benign, 2 = indeterminate, and 3 = malignant) and by consensus (using binary benign/malignant interpretation only). Only lesions within the field of the abdominal scan were evaluated. Clinical and imaging follow-up, histopathology (if available), and the decision of an interdisciplinary truth-panel served as a standard of reference. In addition to the calculation of standard statistical parameters (including general linear mixed models), interobserver reliability was estimated (Cohen's kappa). Results: Of 510 abdominal lesions observed, 354 were classified as malignant. Sensitivity was 77.1% for combined triple-phase CT, 53.4% for arterial CT, 66.1% for portal-venous CT, 66.9% for venous CT, and 72.8% for PET. The respective specificities were 85.3%, 92.9%, 92.3%, 89.7%, and 97.4%, and the respective accuracies were 79.6%, 65.5%, 74.1%, 73.9%, and 80.4%. Although arterial CT was found to be inferior to PET, portal-venous CT, and venous CT (P < 0.001), the differences between the other scans were not significant. Detection was exclusively by PET for 16.1% of lesions, by triple-phase CT for 20.3%, by arterial CT for 0.5%, by portal-venous CT for 3.9%, and by venous CT for 3.9%. Regarding interobserver reliability, the kappa-value was 0.768 for PET, 0.391 for triple-phase CT, 0.577 for arterial CT, 0.583 for portal-venous CT, and 0.482 for venous CT. Conclusion: No CT phase can be omitted in NET imaging, and the triple-phase protocol continues to be strongly recommended also for PET/CT.
引用
收藏
页码:697 / 704
页数:8
相关论文
共 50 条
  • [21] Evaluation of data-driven gating for 68Ga-DOTATOC PET-CT in patients with neuroendocrine tumors
    Sigfridsson, J.
    Romelin, H.
    Lindstrom, E.
    Kvernby, S.
    Velikyan, I.
    Sundin, A.
    Lubberink, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S309 - S310
  • [22] 68Ga-DOTATOC PET/MRI for characterization of undetermined upper abdominal tracer uptake in 68Ga-DOTATOC PET/CT
    Sabet, A.
    Cohnen, J.
    Beiderwellen, K.
    Ezziddin, S.
    Umutlu, L.
    Grafe, H. V.
    Bockisch, A.
    Poeppel, T. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S234 - S234
  • [23] 18F-FDG PET/CT and 68Ga-DOTATOC PET/CT in Diffuse Pancreatic Neuroendocrine Tumor
    Ji, Xia
    Dong, Aisheng
    He, Qi
    Dong, Hui
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (05) : E245 - E248
  • [24] 68Ga-DOTATOC PET/CT and Partial Volume Effects
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) : 25N - 25N
  • [25] Humongous Seminal Vesicles on 68Ga-DOTATOC PET/CT A Rare Presentation of a Neuroendocrine Tumor
    Hendriks, Romee A.
    Hoogendoorn, Stefan P.
    van Gemert, Willemijn A. M.
    Kaal, Suzanne E. J.
    Arens, Anne I. J.
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (12) : 1003 - 1004
  • [26] Role of 68Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours
    Rakesh Kumar
    Punit Sharma
    Pramod Garg
    Sellam Karunanithi
    Niraj Naswa
    Raju Sharma
    Sanjay Thulkar
    Sneh Lata
    Arun Malhotra
    European Radiology, 2011, 21 : 2408 - 2416
  • [27] 68Ga-DOTATOC and 68Ga-PSMA PET/CT Unmasked a Case of Prostate Cancer With Neuroendocrine Differentiation
    Chen, Sirong
    Cheung, Shing Kee
    Wong, Ka-nin
    Wong, Kwok Kee
    Ho, Chi-lai
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) : 959 - 960
  • [28] 68Ga-DOTATOC vs. 68Ga-DOTATATE PET/CT in functional imaging of Neuroendocrine Tumours
    Poeppel, T. D.
    Binse, I.
    Petersenn, S.
    Lahner, H.
    Schott, M.
    Antoch, G.
    Brandau, W.
    Bockisch, A.
    Boy, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S97 - S98
  • [29] Diagnostic Goodness of 68Ga-DOTATOC PET/CT Test to Surface Gastroenteropancreatic Neuroendocrine Tumors (GEP-nets)
    Moreno-Monsalve, T.
    Castellon-Sanchez, M.
    Rodriguez-Lorcano, T.
    Leiva-Montejo, A.
    Ruiz-Corbalan, C.
    De Agrela-Serrao, A.
    Frutos-Esteban, L.
    Navarro-Fernandez, J.
    Caceres-Silva, R.
    Mohamed-Salem, L.
    Hernandez Martinez, A.
    Mears Bano, R.
    Hernandez Almagro, F.
    Contreras-Guitierrez, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S682 - S683
  • [30] Intraindividual Comparison of Selective Arterial versus Venous 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Kratochwil, Clemens
    Giesel, Frederik L.
    Lopez-Benitez, Ruben
    Schimpfky, Nadine
    Kunze, Kirsten
    Eisenhut, Michael
    Kauczor, Hans-Ulrich
    Haberkorn, Uwe
    CLINICAL CANCER RESEARCH, 2010, 16 (10) : 2899 - 2905